#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
John Berman Email
VP Finance & Operations . Larimar Therapeutics
How to contact John Berman
Join and see John's contact info for free!Current Roles
Employees:
55Revenue:
$8.5MAbout
Larimar Therapeutics, Inc. (Nasdaq:LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.Larimar Therapeutics Address
Three Bala Plaza EastBala Cynwyd, PA
United States